Description

NODAGA-LM3 TFA can be labeled by 68Ga for PET imaging. 68Ga-NODAGA-LM3 TFA is a SSTR2 antagonist, and can be used for imaging of SSTR positive paragangliomas[1][2].–80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light)—-C68H90ClN15O19S2.xC2HF3O2—-[1]Fani M, et al. PET of somatostatin receptor-positive tumors using 64Cu- and 68Ga-somatostatin antagonists: the chelate makes the difference. J Nucl Med. 2011 Jul;52(7):1110-8. |[2]Zhu W, et al. A Prospective, Randomized, Double-Blind Study to Evaluate the Safety, Biodistribution, and Dosimetry of 68Ga-NODAGA-LM3 and 68Ga-DOTA-LM3 in Patients with Well-Differentiated Neuroendocrine Tumors. J Nucl Med. 2021 Oct;62(10):1398-1405. —-1521.11 (free acid)–96.35–O=C(N[C@@H]1CC2=CC=C(NC(N)=O)C=C2)[C@H](CC3=CC=C(O)C=C3)NC([C@H](NC([C@H](CC4=CC=C(Cl)C=C4)NC(CC[C@@H](C(O)=O)N5CCN(CC(O)=O)CCN(CC(O)=O)CC5)=O)=O)CSSC[C@@H](C(N[C@H](CC6=CC=C(O)C=C6)C(N)=O)=O)NC([C@]([H])([C@@H](C)O)NC([C@H](CCCCN)NC1=O)=O)=O)=O.O=C(C(F)(F)F)O.[x]–Cancer–10 mM in DMSO–Somatostatin Receptor–SSTR2–GPCR/G Protein;Neuronal Signaling–Peptides